diff --git a/assets/Rethinking_Chagas_Report_21JUN2021-1_1704450708173_0.edn b/assets/Rethinking_Chagas_Report_21JUN2021-1_1704450708173_0.edn index 24dc7b63..c4c6fe18 100644 --- a/assets/Rethinking_Chagas_Report_21JUN2021-1_1704450708173_0.edn +++ b/assets/Rethinking_Chagas_Report_21JUN2021-1_1704450708173_0.edn @@ -251,5 +251,39 @@ :height 1584}), :page 3}, :content {:text "Seek avenues to advocate for policies that will enhance scalability of these efforts and improve care for populations with or at high risk of Chagas disease"}, + :properties {:color "yellow"}} + {:id #uuid "6597ebb7-7e99-46f7-b139-98af95731702", + :page 4, + :position {:bounding {:x1 206.35447311401367, + :y1 1307.7674255371094, + :x2 932.4571342468262, + :y2 1334.7884216308594, + :width 1224, + :height 1584}, + :rects ({:x1 206.35447311401367, + :y1 1307.7674255371094, + :x2 932.4571342468262, + :y2 1334.7884216308594, + :width 1224, + :height 1584}), + :page 4}, + :content {:text "Re-engage Ortho in discussions to make its T. cruzi ELISA commercially available."}, + :properties {:color "yellow"}} + {:id #uuid "6597ebbe-e6fb-4b11-8901-8a4dc8950543", + :page 4, + :position {:bounding {:x1 206.35447311401367, + :y1 1348.6298522949219, + :x2 939.6749076843262, + :y2 1375.6508483886719, + :width 1224, + :height 1584}, + :rects ({:x1 206.35447311401367, + :y1 1348.6298522949219, + :x2 939.6749076843262, + :y2 1375.6508483886719, + :width 1224, + :height 1584}), + :page 4}, + :content {:text "Explore opportunities to reduce the entry barrier for new tests, including rapid tests"}, :properties {:color "yellow"}}], - :extra {:page 4}} + :extra {:page 5}} diff --git a/pages/hls__Rethinking_Chagas_Report_21JUN2021-1_1704450708173_0.md b/pages/hls__Rethinking_Chagas_Report_21JUN2021-1_1704450708173_0.md index 1c00a5b8..49960f64 100644 --- a/pages/hls__Rethinking_Chagas_Report_21JUN2021-1_1704450708173_0.md +++ b/pages/hls__Rethinking_Chagas_Report_21JUN2021-1_1704450708173_0.md @@ -50,4 +50,14 @@ file-path:: ../assets/Rethinking_Chagas_Report_21JUN2021-1_1704450708173_0.pdf ls-type:: annotation hl-page:: 3 hl-color:: yellow - id:: 6597eb2f-6e68-4b48-b4b2-52d1d6ff2fa0 \ No newline at end of file + id:: 6597eb2f-6e68-4b48-b4b2-52d1d6ff2fa0 +- Re-engage Ortho in discussions to make its T. cruzi ELISA commercially available. + ls-type:: annotation + hl-page:: 4 + hl-color:: yellow + id:: 6597ebb7-7e99-46f7-b139-98af95731702 +- Explore opportunities to reduce the entry barrier for new tests, including rapid tests + ls-type:: annotation + hl-page:: 4 + hl-color:: yellow + id:: 6597ebbe-e6fb-4b11-8901-8a4dc8950543 \ No newline at end of file